News & Views
- Posted By: TreehillPartners
- In: Business Development & Licensing, Drug Development, Leadership & Restructuring, Strategy & Corporate Development
Chinese biotech's advance has been as ferocious as the nation's breakthrough efforts in AI and EVs, eclipsing the EU and catching up to the US...
- Posted By: TreehillPartners
- In: Strategy & Corporate Development
Companies are being asked to take-on increasingly complex challenges in an environment where there are diminished resources...
- Posted By: TreehillPartners
- In: Dealmaking, Drug Development, Leadership & Restructuring, Strategy & Corporate Development
Mandy Jackson, US editor of Citeline's Scrip, has published the below interview with Ali Pashazadeh, Treehill Partners CEO...
- Posted By: TreehillPartners
- In: Drug Development, Financing & Capital Markets, Strategy & Corporate Development
At this year's BIO Convention in Boston, Ali Pashazadeh, Treehill Partners CEO, spoke with Manasee Kurlekar, BioSpectrum Asia Chief Executive Officer...
- Posted By: TreehillPartners
- In: Drug Development, Strategy & Corporate Development